Literature DB >> 23705899

Serum response factor indirectly regulates type I interferon-signaling in macrophages.

Lan Xie1, Amy L Sullivan, Jana G Collier, Christopher K Glass.   

Abstract

Serum response factor (SRF) is required for diverse aspects of development and homeostasis, but potential roles in the regulation of inflammation and immunity have not been systematically investigated. Here, we demonstrate that SRF is unexpectedly required for optimal responses of elicited peritoneal macrophages to type I interferons. Knockdown of SRF expression in these cells impairs induction of numerous interferon (IFN)-stimulated genes (ISGs) in response to zymosan, LPS, and poly I:C. This effect is primarily due to a defect in the ability of induced type I interferons to mediate secondary activation of ISGs. SRF does not appear to be required for expression of established components of the type I interferon signaling pathway, with IFN-β-dependent phosphorylation of STAT1 and STAT2 normally occurring in SRF-depleted macrophages. Collectively, these findings suggest that SRF can indirectly modulate type I interferon-signaling, without interfering with the classic JAK/STAT/ISGF3 pathway.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23705899      PMCID: PMC3793656          DOI: 10.1089/jir.2012.0065

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  33 in total

Review 1.  Toll-like receptor signalling.

Authors:  Shizuo Akira; Kiyoshi Takeda
Journal:  Nat Rev Immunol       Date:  2004-07       Impact factor: 53.106

2.  Toll-like receptor signaling pathways.

Authors:  Gregory M Barton; Ruslan Medzhitov
Journal:  Science       Date:  2003-06-06       Impact factor: 47.728

3.  Interferons up-regulate STAT1, STAT2, and IRF family transcription factor gene expression in human peripheral blood mononuclear cells and macrophages.

Authors:  A Lehtonen; S Matikainen; I Julkunen
Journal:  J Immunol       Date:  1997-07-15       Impact factor: 5.422

4.  Interferon-induced nuclear factors that bind a shared promoter element correlate with positive and negative transcriptional control.

Authors:  D E Levy; D S Kessler; R Pine; N Reich; J E Darnell
Journal:  Genes Dev       Date:  1988-04       Impact factor: 11.361

5.  Neuronal migration in the murine rostral migratory stream requires serum response factor.

Authors:  Siegfried Alberti; Sven M Krause; Oliver Kretz; Ulrike Philippar; Thomas Lemberger; Emilio Casanova; Franziska F Wiebel; Heinz Schwarz; Michael Frotscher; Günther Schütz; Alfred Nordheim
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-18       Impact factor: 11.205

6.  Restricted inactivation of serum response factor to the cardiovascular system.

Authors:  Joseph M Miano; Narendrakumar Ramanan; Mary A Georger; Karen L de Mesy Bentley; Rachael L Emerson; Robert O Balza; Qi Xiao; Hartmut Weiler; David D Ginty; Ravi P Misra
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-29       Impact factor: 11.205

7.  Crystal structure of ATF-2/c-Jun and IRF-3 bound to the interferon-beta enhancer.

Authors:  Daniel Panne; Tom Maniatis; Stephen C Harrison
Journal:  EMBO J       Date:  2004-10-28       Impact factor: 11.598

Review 8.  Evasion of intracellular host defence by hepatitis C virus.

Authors:  Michael Gale; Eileen M Foy
Journal:  Nature       Date:  2005-08-18       Impact factor: 49.962

9.  Identification of a protein-binding site that mediates transcriptional response of the c-fos gene to serum factors.

Authors:  R Treisman
Journal:  Cell       Date:  1986-08-15       Impact factor: 41.582

Review 10.  Serum response factor: toggling between disparate programs of gene expression.

Authors:  Joseph M Miano
Journal:  J Mol Cell Cardiol       Date:  2003-06       Impact factor: 5.000

View more
  6 in total

1.  Mouse Cd59b but not Cd59a is upregulated to protect cells from complement attack in response to inflammatory stimulation.

Authors:  J Chen; Y Du; P Ding; X Zhang; L Zhang; N Wang; W Hu
Journal:  Genes Immun       Date:  2015-07-23       Impact factor: 2.676

2.  Identification of Two Genetic Loci Associated with Leukopenia after Chemotherapy in Patients with Breast Cancer.

Authors:  Peter A Fasching; Duan Liu; Steve Scully; Lothar Häberle; Richard M Weinshilboum; Liewei Wang; James N Ingle; Paulo C Lyra; Brigitte Rack; Alexander Hein; Arif B Ekici; Andre Reis; Andreas Schneeweiss; Hans Tesch; Tanja N Fehm; Georg Heinrich; Matthias W Beckmann; Matthias Ruebner; Hanna Huebner; Diether Lambrechts; Ebony Madden; Jess Shen; Jane Romm; Kim Doheny; Gregory D Jenkins; Erin E Carlson; Liang Li; Brooke L Fridley; Julie M Cunningham; Wolfgang Janni; Alvaro N A Monteiro; Daniel J Schaid
Journal:  Clin Cancer Res       Date:  2022-08-02       Impact factor: 13.801

3.  RNase L attenuates mitogen-stimulated gene expression via transcriptional and post-transcriptional mechanisms to limit the proliferative response.

Authors:  Sarah E Brennan-Laun; Xiao-Ling Li; Heather J Ezelle; Thiagarajan Venkataraman; Perry J Blackshear; Gerald M Wilson; Bret A Hassel
Journal:  J Biol Chem       Date:  2014-10-09       Impact factor: 5.157

4.  MKL1/2 and ELK4 co-regulate distinct serum response factor (SRF) transcription programs in macrophages.

Authors:  Lan Xie
Journal:  BMC Genomics       Date:  2014-04-23       Impact factor: 3.969

5.  A three step network based approach (TSNBA) to finding disease molecular signature and key regulators: a case study of IL-1 and TNF-alpha stimulated inflammation.

Authors:  Jihong Yang; Zheng Li; Xiaohui Fan; Yiyu Cheng
Journal:  PLoS One       Date:  2014-04-18       Impact factor: 3.240

Review 6.  Molecular Mechanisms of Leukocyte Migration and Its Potential Targeting-Lessons Learned From MKL1/SRF-Related Primary Immunodeficiency Diseases.

Authors:  Evelien G G Sprenkeler; Carla Guenther; Imrul Faisal; Taco W Kuijpers; Susanna C Fagerholm
Journal:  Front Immunol       Date:  2021-02-22       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.